Spinal Cord Injury Exercise and Nutrition Conceptual Engagement
SCIENCE
3 other identifiers
interventional
26
1 country
1
Brief Summary
Evaluate and compare the health benefits of an at home exercise program using functional electrical stimulation (FES) for lower extremity exercise with diet versus a diet alone group in adults with spinal cord injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2018
CompletedFirst Posted
Study publicly available on registry
April 12, 2018
CompletedStudy Start
First participant enrolled
June 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2024
CompletedResults Posted
Study results publicly available
December 22, 2025
CompletedDecember 22, 2025
December 1, 2025
3.1 years
March 2, 2018
July 23, 2025
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Percent Body Fat Assessed by DXA at Baseline and 21 Weeks
Percent body fat will be assessed in percentage using Dual Energy x-ray absorbency (DXA). Assessments will be conducted at baseline and at 21 weeks to evaluate changes in body composition over time.
Baseline, 21 weeks
Fat Free Mass
Body composition will be assessed using Dual-Energy X-ray Absorptiometry (DXA), which provides precise measurements of both absolute fat mass (FM) and absolute fat-free mass (FFM) in kilograms. FFM represents a distinct component of total body mass and will be used to evaluate lean tissue (i.e.,FFM) over time.
Baseline, 21 weeks
Change in Insulin Sensitivity (Si)
Insulin Sensitivity will be measured using intravenous glucose tolerance test (IVGTT)
Baseline, 21 weeks
Change in Glucose Effectiveness (Sg)
Glucose Effectiveness will be measured using IVGTT
Baseline, 21 weeks
Change in Basal Metabolic Rate (BMR)
BMR will be measured by indirect calorimetry
Baseline, 21 weeks
Secondary Outcomes (4)
High Density Lipoprotein Cholesterol (HDL-C)
Baseline, 21 weeks
Change in Total Cholesterol : HDL-C Ratio
Baseline, 21 weeks
C-Reactive Protein (hsCRP)
Baseline, 21 weeks
Lower Extremity Bone Mineral Density (BMD) - Femur
Baseline, 21 weeks
Study Arms (2)
Home-Based Exercise & Diet Group
EXPERIMENTAL16-week home based functional electrical stimulation leg cycle ergometry exercise program and diet intervention
Home-Based Diet Alone Group
PLACEBO COMPARATORDiet intervention
Interventions
Exercise training will consist of three to five, 40-67 minute sessions (200 minutes at target intensity) each week for a total of 16 weeks at 70% maximal heart rate; 10-minute warm-up and cool-down sessions will accompany each exercise session.
An individualized, detailed dietary plan consistent with My Healthy Plate Dietary Guidelines of America will be followed under supervision of Registered Dietitian with weekly telemedicine conferences and monitored dietary intake via MyFitnessPal.
Eligibility Criteria
You may qualify if:
- Adults 18-65 years of age (inclusive)
- Sex: male or female
- Women of child-bearing potential who agree to refrain from getting pregnant during the trial
- C4-T4 motor complete (AIS A\&B) spinal cord injury for duration greater than 12 months
- \<5% change in body weight over the past 12 months
You may not qualify if:
- \<22% body fat
- Unresponsive to neurostimulation
- Those who have participated in an FES or ACE exercise program (\>60 minutes/week) within the past 3 months
- Known orthopaedic limitations
- Coronary artery disease
- Type 1 diabetes mellitus, insulin-requiring Type 2 or untreated diabetes mellitus (fasting glucose\>126 or HgbA1c\>7.0)
- Uncompensated Hypothyroidism (Stable on medication \>1 year or not on medication)
- Renal disease
- Uncontrolled autonomic dysreflexia, recent (within 3 months)
- Deep vein thrombosis
- Pressure ulcers \> Grade II
- Decisional impairment
- Any potential causes of autonomic dysreflexia at the discretion of the PI
- Prisoners
- Pregnant or nursing women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Eduard Tiozzo
- Organization
- University of Miami Miller School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Eduard Tiozzo, PhD, MSCTI
University of Miami
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
March 2, 2018
First Posted
April 12, 2018
Study Start
June 10, 2021
Primary Completion
July 24, 2024
Study Completion
July 24, 2024
Last Updated
December 22, 2025
Results First Posted
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share